2 terminated, 1 suspended. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Suspended 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow alpha-Methyltyrosine: new trials by email Literature Review of alpha-Methyltyrosine trials Research Report on alpha-Methyltyrosine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET Methylphenidate, Alpha Methyl Para Tyrosine (AMPT), [11C]PHNO - Cocaine Dependence | Not applicable | Terminated | Yale University | 1 | 2014-05-01 | 2023-02-16 |
| Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls AMPT/ Demser, Diphenhydramine, Placebo - Bulimia Nervosa, Eating Disorders | Not applicable | Suspended | University of Bern | 60 | 2012-02-20 | 2019-01-24 |
| Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Metyrosine, Placebo - Velo-cardio-facial Syndrome, Psychosis | Phase 2 | Terminated | Bausch Health Americas, Inc. | 2 | 2010-06-01 | 2019-11-22 |
Bulimia Nervosa (1) · Cocaine-Related Disorders (1) · DiGeorge Syndrome (1) · Feeding and Eating Disorders (1) · Psychotic Disorders (1)
Bausch Health Americas, Inc. (1) · University of Bern (1) · Yale University (1)
United States (2) · Switzerland (1)
Gregor Hasler, Prof. Dr. med (1) · Robert J Shprintzen, PhD (1) · Robert Malison, MD (1)